Table of Contents
- Introduction to Aeromonas hydrophila
- Taxonomy and Classification of Aeromonas hydrophila
- Morphology and Microscopy of Aeromonas hydrophila
- Cultural and Growth Characteristics of Aeromonas hydrophila
- Biochemical and Identification Tests of Aeromonas hydrophila
- Pathogenesis of Aeromonas hydrophila
- Virulence Factors of Aeromonas hydrophila
- Epidemiology of Aeromonas hydrophila
- Transmission of Aeromonas hydrophila
- Clinical Manifestations of Aeromonas hydrophila
- Laboratory Diagnosis of Aeromonas hydrophila
- Treatment of Aeromonas hydrophila
- Prevention and Control of Aeromonas hydrophila
- Conclusion
- References
Introduction to Aeromonas hydrophila
- Aeromonas hydrophila is a Gram-negative, facultatively anaerobic bacterium belonging to the family Aeromonadaceae.
- It is widely distributed in aquatic environments and is commonly isolated from freshwater, brackish water, and soil.
- The bacterium is an important colonizer and opportunistic pathogen of ectothermic (cold-blooded) animals, particularly fish, reptiles, and amphibians.
- The genome of A. hydrophila is approximately 4.5–5.0 Mbp in size and generally has a high GC content of about 61–62%.
- Some strains harbor plasmids that may carry genes associated with virulence and antimicrobial resistance, contributing to their pathogenic potential and adaptability.
- A. hydrophila produces several important virulence factors, including hemolysin and aerolysin, which contribute to tissue damage and disease development.
- The species exhibits antimicrobial resistance, with resistance to ampicillin being particularly common. Some strains have also been reported to exhibit multidrug resistance (MDR).
- Because of its widespread environmental distribution, pathogenic potential, antimicrobial resistance, and importance in aquaculture and human health, A. hydrophila is an important organism in microbiological, veterinary, environmental, and medical research.
Taxonomy and Classification of Aeromonas hydrophila
- Domain: Bacteria
- Kingdom: Pseudomonadota
- Phylum: Pseudomonadota
- Class: Gammaproteobacteria
- Order: Aeromonadales
- Family: Aeromonadaceae
- Genus: Aeromonas
- Species: Aeromonas hydrophila (A. hydrophila)
Morphology and Microscopy of Aeromonas hydrophila
- Aeromonas hydrophila is a Gram-negative, rod-shaped (bacillary) bacterium with generally rounded ends.
- Cells may exhibit different morphological forms, appearing as straight or slightly curved rods, coccobacilli, and occasionally filamentous forms.
- The typical cell size is approximately 0.3–1.0 µm in width and 1.0–3.5 µm in length.
- It is generally motile, primarily due to the presence of polar flagella.
- A. hydrophila is a non-spore-forming bacterium.
- Cells may possess a capsule or capsular material, although capsule expression can vary among strains and growth conditions.
- Following Gram staining, the cells appear as short, pink to reddish rods under a light microscope because they do not retain the crystal violet–iodine complex and take up the counterstain.
- Microscopically, the cells may occur singly, in pairs, or occasionally in short chains.
Cultural and Growth Characteristics of Aeromonas hydrophila
- Aeromonas hydrophila is a facultatively anaerobic bacterium, allowing it to grow under both oxygen-rich and oxygen-limited conditions.
- It can grow over a relatively broad temperature range, with an optimum growth temperature of approximately 25–35°C.
- The organism tolerates a relatively broad pH range, with reported growth around pH 5.5–9.0.
- A. hydrophila can grow on a variety of routine and selective culture media, including Nutrient Agar, Blood Agar, MacConkey Agar, Aeromonas Medium Base, Tryptone Soya Agar, and Rimler–Shotts Agar.
Colony Characteristics on Different Media
- Nutrient Agar: Produces smooth, circular, convex colonies that are generally colorless to pale yellow and may have a characteristic odor.
- Blood Agar: Produces approximately 1–3 mm, round to circular, convex, translucent colonies. Many strains show β-hemolysis, resulting in clear zones around the colonies.
- MacConkey Agar: Typically forms pale, colorless to slightly pink colonies due to its usual inability to ferment lactose.
- Aeromonas Medium Base: May produce small, circular green colonies with darker centers, providing a characteristic appearance on this selective/differential medium.
- Tryptone Soya Agar (TSA): Forms round, smooth, yellowish to creamy colonies.
- Rimler–Shotts Agar: Produces small, smooth, spherical, convex, yellowish colonies, which can assist in the selective isolation and presumptive identification of Aeromonas species.
Note: Colony morphology can vary depending on the strain, incubation conditions, medium composition, incubation time, and environmental factors. Therefore, cultural characteristics should be interpreted together with biochemical and/or molecular identification methods.
Biochemical and Identification Tests of Aeromonas hydrophila
| Test | Result |
|---|---|
| Catalase | Positive |
| Oxidase | Positive |
| Indole | Positive |
| OF (Oxidative-Fermentative) | Fermentative |
| VP (Voges-Proskauer) | Positive |
| TSIA (Triple Sugar Iron Agar) | Alkali/Acid |
| Urease | Negative |
| H2S | Positive |
| Citrate | Positive |
| Gelatin Hydrolysis | Positive |
| Nitrate Reduction | Positive |
| Fermentation of Carbohydrates | |
| Arabinose | Variable |
| Arabitol | Negative |
| DNase | Positive |
| Dulcitol | Negative |
| Erythritol | Negative |
| Glucose | Positive |
| Gluconate | Variable |
| Lactose | Variable |
| Mannitol | Positive |
| Mucate | Negative |
| Rhamnose | Negative |
| Sorbitol | Negative |
| Sucrose | Positive |
| Trehalose | Positive |
| Xylose | Negative |
| Enzymatic Reactions | |
| Arbutin | Positive |
| Arginine Dehydrolase | Positive |
| Elastase | Positive |
| Esculin Hydrolysis | Positive |
| Lysine Decarboxylase | Positive |
| Ornithine Decarboxylase | Negative |
| Pectinase | Positive |
| Phenylalanine Deaminase | Negative |
| Pyrazinamidase | Positive |
Note: Biochemical characteristics may vary among Aeromonas hydrophila strains and can be influenced by culture conditions and testing methods. Results should therefore be interpreted together with other phenotypic and/or molecular identification methods.
Pathogenesis of Aeromonas hydrophila
- Entry into the host: Infection begins when A. hydrophila gains access to the host through contaminated food or water, damaged skin, gills, or the gastrointestinal tract.
- Attachment and colonization: The bacterium uses polar flagella, fimbriae, and outer membrane proteins to attach to epithelial surfaces. These structures facilitate initial colonization and interaction with host tissues.
- Motility and chemotaxis: The polar flagellum plays an important role in bacterial motility and contributes to adhesion and invasion. Through motility and chemotaxis, the bacterium can move toward favorable environmental conditions and target mucosal surfaces.
- Biofilm formation: After attachment, A. hydrophila can form biofilms, which promote persistence on host surfaces and provide protection against environmental stresses and components of host defense.
- Production of virulence factors: Once established, the bacterium produces a range of toxins and extracellular enzymes, including aerolysin, hemolysins, enterotoxins, proteases, and other tissue-degrading enzymes.
- Cell damage and tissue injury: Aerolysin and hemolysins can damage host-cell membranes through pore-forming activity and contribute to cell lysis, tissue injury, necrosis, and hemorrhage.
- Intestinal effects: Enterotoxins and other virulence-associated factors can interfere with intestinal epithelial function, promoting fluid secretion, inflammation, and diarrhea.
- Tissue invasion: Proteases and other extracellular enzymes can degrade components of host tissues and extracellular matrices, facilitating local tissue damage, bacterial invasion, and dissemination.
- Iron acquisition: A. hydrophila possesses iron-acquisition mechanisms that enable it to obtain iron from the host environment, supporting bacterial growth during infection.
- Evasion of host defenses: Surface components such as lipopolysaccharide (LPS) and capsule, together with other virulence-associated mechanisms, can contribute to resistance against phagocytosis and complement-mediated killing.
- Systemic dissemination: In severe infections, the bacterium may enter the bloodstream, resulting in bacteremia or septicemia and potentially causing systemic tissue and organ damage.
Pathogenesis in Fish
- In fish, A. hydrophila is an important cause of motile Aeromonas septicemia (MAS), particularly under conditions that compromise host health or immunity.
- The disease may be associated with hemorrhagic lesions, skin ulceration, edema or ascites, internal organ involvement, and high mortality, depending on the host, strain, and environmental conditions.
Pathogenesis in Humans
- In humans, A. hydrophila can cause gastroenteritis and diarrhea, particularly following exposure through contaminated food or water.
- It can also cause wound and soft-tissue infections, especially when damaged tissue is exposed to contaminated water.
- In susceptible individuals or severe infections, the organism can disseminate systemically and cause bacteremia or septicemia, which may become life-threatening.
Virulence Factors of Aeromonas hydrophila
1. Secretion Systems
Type II Secretion System (T2SS)
- The Type II Secretion System is important for transporting bacterial toxins and extracellular enzymes from the periplasm to the external environment.
- It contributes to pathogenicity by secreting several virulence-associated factors, including:
- Aerolysin
- Amylases
- DNases
- Proteases
- These secreted factors contribute to tissue damage, nutrient acquisition, colonization, and bacterial dissemination.
Type III Secretion System (T3SS)
- The Type III Secretion System functions as a specialized molecular injection apparatus, delivering bacterial effector proteins directly into host cells.
- These effectors can interfere with host-cell signaling, cytoskeletal functions, immune responses, and cell survival.
- T3SS expression and activity can be influenced by several environmental and host-associated signals, including:
- Contact with host cells
- Temperature
- Calcium and magnesium concentrations
- Quorum sensing
- Flagellar systems
- Lipopolysaccharide-associated regulation
- DNA adenine methylation and other regulatory mechanisms
- Proper secretion also requires effectors to possess appropriate secretion signals.
Type IV Secretion System (T4SS)
- The Type IV Secretion System is a specialized transport apparatus capable of delivering bacterial molecules, including proteins and other effectors, into target cells or the surrounding environment.
- It has structural similarities to conjugative systems and phage-like secretion machinery.
- In A. hydrophila, components associated with this system can contribute to virulence, host-cell interaction, and bacterial competition.
- Valine-glycine repeat proteins and hemolysin-coregulated protein (Hcp) have been associated with secretion-associated functions and host or bacterial interactions.
2. Biofilm Formation
- Biofilms are structured bacterial communities embedded within an extracellular polymeric matrix.
- Biofilm formation enables A. hydrophila to:
- Persist in aquatic environments and host tissues.
- Increase resistance to antimicrobial agents.
- Reduce susceptibility to immune clearance.
- Promote long-term colonization.
- Facilitate bacterial survival under unfavorable environmental conditions.
- Biofilm-associated cells can therefore contribute to persistent infection and environmental survival.
3. Flagella
- Flagella are important surface structures involved in motility and host colonization.
- They:
- Facilitate movement toward favorable environments and host tissues.
- Contribute to the initial attachment of bacteria to epithelial surfaces.
- Promote colonization of mucosal tissues.
- Participate in biofilm development.
- Flagellar activity can also contribute to chemotaxis, allowing bacteria to respond to chemical gradients.
4. Pili
- Pili are hair-like surface appendages that contribute to bacterial attachment and colonization.
- They:
- Promote adhesion to host epithelial cells.
- Facilitate interactions with receptors on intestinal and skin tissues.
- Support stable colonization.
- Contribute to biofilm development.
- By strengthening bacterial attachment, pili can increase the ability of A. hydrophila to establish itself on host surfaces.
5. Outer Membrane Proteins (OMPs)
- Outer membrane proteins are important structural and functional components of the A. hydrophila cell envelope.
- They contribute to:
- Adhesion to host cells.
- Transport of nutrients and other molecules.
- Interaction with host tissues.
- Biofilm formation.
- Some OMPs can also participate in interactions with the host immune system.
6. Aerolysin
- Aerolysin is one of the major pore-forming toxins associated with A. hydrophila pathogenicity.
- It is produced as an inactive protoxin that undergoes activation before exerting its full cytotoxic effect.
- The activated toxin binds to susceptible host-cell membranes and forms transmembrane pores.
- Its effects can include:
- Cell membrane disruption.
- Cell lysis.
- Hemolysis.
- Tissue injury and necrosis.
- Increased vascular permeability.
- Aerolysin therefore contributes significantly to host-cell damage and disease progression.
7. Hemolysins
- Hemolysins are cytolytic toxins that can damage erythrocytes and other host cells.
- They contribute to:
- Red blood cell lysis.
- Release of intracellular nutrients, including iron-containing compounds.
- Tissue injury.
- Hemorrhagic lesions.
- Inflammatory responses.
- Hemolytic activity is an important characteristic associated with the pathogenic potential of some A. hydrophila strains.
8. Cytotonic Enterotoxins
- Cytotonic enterotoxins interfere with intestinal epithelial-cell signaling and can increase intracellular cAMP and/or cGMP.
- This promotes:
- Chloride and electrolyte secretion.
- Movement of water into the intestinal lumen.
- Increased intestinal fluid secretion.
- These effects contribute to watery or secretory diarrhea associated with Aeromonas gastrointestinal infections.
9. Extracellular Enzymes
Proteases
- Proteases degrade host proteins, including components of the extracellular matrix and, in some cases, immune-associated proteins.
- Their activities can contribute to:
- Tissue destruction.
- Breakdown of structural proteins.
- Facilitation of bacterial invasion.
- Modulation or evasion of host immune defenses.
Elastase
- Elastase is an extracellular enzyme that degrades elastin, an important component of connective and vascular tissues.
- It can contribute to:
- Connective-tissue degradation.
- Vascular tissue damage.
- Tissue invasion.
- Dissemination of infection.
Lipases
- Lipases hydrolyze lipids and ester bonds in lipid-containing substrates.
- Their activity can contribute to:
- Disruption of lipid-containing cellular structures.
- Tissue damage.
- Nutrient acquisition.
- Lipase activity may act synergistically with other extracellular enzymes and toxins.
Phospholipases
- Phospholipases hydrolyze phospholipids, important structural components of cell membranes.
- They can contribute to:
- Membrane disruption.
- Cell damage and lysis.
- Tissue injury.
- Modulation of inflammatory responses.
DNases
- DNases degrade extracellular DNA.
- This activity can help bacteria:
- Break down extracellular DNA within biofilm matrices.
- Modify the local extracellular environment.
- Potentially degrade DNA associated with neutrophil extracellular traps (NETs).
- Facilitate movement through infected tissues.
Gelatinases
- Gelatinases are proteolytic enzymes capable of degrading gelatin and other extracellular-matrix-associated proteins.
- They contribute to:
- Breakdown of connective-tissue components.
- Tissue invasion.
- Expansion of tissue lesions.
- Nutrient acquisition.
10. Capsule
- The capsule is an extracellular polysaccharide-rich layer surrounding the bacterial cell in encapsulated strains.
- It can contribute to immune evasion by:
- Reducing efficient phagocytic uptake.
- Interfering with complement-mediated bacterial clearance.
- Protecting bacteria from unfavorable host conditions.
- Capsule-associated protection can enhance bacterial persistence, particularly during systemic infection.
11. Lipopolysaccharide (LPS)
- Lipopolysaccharide (LPS) is an important component of the outer membrane of Gram-negative A. hydrophila.
- Its lipid A component can activate host innate immune responses.
- Excessive inflammatory activation can contribute to:
- Cytokine release.
- Systemic inflammation.
- Vascular dysfunction.
- Severe sepsis and, in serious cases, septic shock.
- LPS also contributes to the structural integrity of the bacterial outer membrane and interactions with the host immune system.
12. Iron Acquisition Systems
Siderophores
- Iron is an essential nutrient but is strongly restricted within the host by nutritional immunity.
- A. hydrophila can produce or utilize siderophores, which are high-affinity iron-chelating molecules.
- Siderophores help bacteria obtain iron from host-associated iron-binding proteins and other environmental sources.
- This provides an important advantage for bacterial growth under iron-limited conditions.
- Efficient iron acquisition can therefore support:
- Bacterial multiplication.
- Persistence in host tissues.
- Expression of iron-dependent virulence functions.
- Survival during infection.
Overall Role of Virulence Factors
The pathogenicity of A. hydrophila does not depend on a single virulence factor. Instead, secretion systems, toxins, adhesins, motility structures, extracellular enzymes, biofilm formation, immune-evasion mechanisms, LPS, and iron-acquisition systems act together to support colonization, tissue damage, immune interaction, persistence, and dissemination.
Epidemiology of Aeromonas hydrophila
- Aeromonas hydrophila has a worldwide distribution and is associated with both environmental reservoirs and human infections.
- It is commonly isolated from a variety of environmental and food-associated sources, including:
- Freshwater
- Sewage
- Soil
- Fruits
- Vegetables
- Its widespread presence in aquatic environments makes contaminated water and food important potential sources of human exposure.
- Epidemiological studies have reported varying prevalence rates of A. hydrophila among patients with diarrhea in different geographic regions.
- In India, A. hydrophila was detected in 9% of 1,595 diarrheal stool samples.
- In Kenya, A. hydrophila was detected in 5 of 188 stool samples, corresponding to approximately 2.7%.
- In Shanghai, China, A. hydrophila was identified in 5.7% of 4,529 diarrheal samples.
- In Beijing, China, A. hydrophila was detected in 5.2% of 1,286 samples collected from patients with acute diarrhea.
- These findings demonstrate that A. hydrophila occurs among diarrheal patients in geographically diverse populations, although reported prevalence varies between studies.
- Clinical studies from different countries have also documented the occurrence of A. hydrophila in patient samples.
- In Spain, between January 2015 and December 2017, A. hydrophila was identified in 1 of 98 patient samples examined.
- In Australia, A. hydrophila was detected in 20% of 100 analyzed samples.
- A study conducted in Mexico and Spain analyzed 109 samples and identified A. hydrophila as the predominant Aeromonas species.
- In Barcelona, Spain, from January 2006 to December 2012, 221 positive cases of Aeromonas spp. were reported, of which 204 isolates were identified as A. hydrophila.
- The epidemiology of A. hydrophila reflects its ability to survive in diverse environmental and clinical settings.
- Its occurrence in freshwater and sewage highlights the importance of aquatic environments as potential reservoirs.
- Detection in fruits and vegetables also indicates a potential role of food-associated exposure in transmission.
- Differences in reported prevalence may be influenced by geographical location, environmental exposure, patient population, sample size, study period, laboratory detection methods, and sampling strategies.
- A. hydrophila is therefore of importance in environmental microbiology, food safety, aquaculture, veterinary medicine, and human infectious disease research.
- The reported percentages represent individual study findings rather than a single global prevalence estimate, and differences in study populations and sampling methods should be considered when comparing them.
Transmission of Aeromonas hydrophila
Transmission of Aeromonas hydrophila
Explore the major routes through which A. hydrophila can move from environmental reservoirs to humans, animals, food, and aquatic systems.
A. hydrophila
ROUTE 1 OF 8
Waterborne Transmission
1 / 8
Clinical Manifestations of Aeromonas hydrophila
Clinical Manifestations in Humans
Gastrointestinal manifestations
Acute gastroenteritis
- Abdominal cramps and abdominal pain
- Watery diarrhea, which may occasionally become dysentery-like
- Nausea
- Vomiting
- Low-grade fever
- Symptoms may be self-limiting in otherwise healthy individuals.
Severe gastrointestinal disease
- Mucoid or bloody diarrhea
- Dehydration, particularly in children and older adults
Traveler’s diarrhea-like illness
- Sudden onset of watery diarrhea
- Mild fever
- Malaise
Skin and soft-tissue infections
Wound infections
- Cellulitis characterized by redness, swelling, and pain
- Purulent discharge
- Local tenderness and warmth
Traumatic wound infections
- May develop when an injury is exposed to contaminated freshwater
- Infection can progress rapidly, particularly in susceptible individuals
Necrotizing fasciitis
- Severe pain that may be disproportionate to the visible lesion
- Rapid destruction of soft tissues
- Skin discoloration, which may progress to dark or black areas
- Bullae or blister formation
- Foul-smelling wound discharge
- Systemic toxicity
Myonecrosis
- Destruction of muscle tissue
- Severe pain and swelling
- May progress to systemic infection and sepsis
Systemic infections
Bacteremia
- Fever
- Chills
- Malaise
Sepsis/septicemia
- High fever or, in severe illness, hypothermia
- Tachycardia
- Hypotension
- Multi-organ dysfunction
Endocarditis
- Fever
- Heart murmur
- Potential embolic complications
Meningitis
- Headache
- Neck stiffness
- Fever
- Altered consciousness
- Hepatobiliary and other infections
- Cholecystitis
- Liver abscess
- Peritonitis
Ocular infections
- Conjunctivitis
- Keratitis
- Eye pain
- Ocular redness
- Visual disturbances
Clinical Manifestations in Fish — Motile Aeromonas Septicemia
External signs
- Hemorrhagic lesions on the skin
- Skin ulcers and erosions
- Fin rot and tail rot
- Exophthalmia, characterized by bulging or protruding eyes
Internal signs
- Ascites, characterized by accumulation of fluid within the abdominal cavity
- Enlargement of the liver
- Enlargement of the spleen
- Enlargement of the kidneys
- Hemorrhages involving internal organs
Laboratory Diagnosis of Aeromonas hydrophila
- Sample Collection: The type of clinical sample depends on the site and type of infection.
- Gastroenteritis: Stool sample, rectal swab.
- Wound and soft tissue infections: Pus, wound swab, tissue biopsy.
- Septicemia: Blood.
- Other infections: Cerebrospinal fluid (CSF), peritoneal fluid, eye swabs, and other tissue samples.
- Microscopy: After Gram staining, A. hydrophila appears as short, straight, Gram-negative rods with rounded ends and pink to red coloration. Microscopy provides preliminary evidence of infection but cannot definitively identify A. hydrophila.
- Culture: A. hydrophila grows well on routine media such as nutrient agar, blood agar, and MacConkey agar. Growth commonly occurs within 18–24 hours under suitable conditions at approximately 25–35°C.
- Nutrient Agar: Smooth, circular, convex, colorless to pale-yellow colonies with a characteristic odor may develop.
- Blood Agar: Approximately 1–3 mm, round, circular, convex, translucent, and commonly β-hemolytic colonies are produced.
- MacConkey Agar: Pale, colorless to slightly pink colonies are observed.
- Aeromonas Medium Base: Small, circular, green colonies with darker centers are produced.
- Tryptone Soya Agar (TSA): Round, smooth, yellowish to creamy colonies are observed.
- Rimler-Shotts Agar: Small, smooth, spherical, convex, yellowish colonies are formed.
- Biochemical Tests: Following culture, suspected colonies are subjected to biochemical tests to support identification of A. hydrophila. The typical results include:
- Catalase: Positive.
- Oxidase: Positive.
- Indole: Positive.
- OF (Oxidative-Fermentative): Fermentative.
- VP (Voges–Proskauer): Positive.
- TSIA (Triple Sugar Iron Agar): Alkali/Acid.
- Urease: Negative.
- H₂S: Positive.
- Citrate: Positive.
- Gelatin hydrolysis: Positive.
- Nitrate reduction: Positive.
- Commercial Identification Systems: Automated identification systems such as API 20E, VITEK 2, and BD Phoenix can be used for rapid identification of Aeromonas species and provide standardized biochemical profiles.
- Polymerase Chain Reaction (PCR): PCR can target genes such as aerA, hlyA, act, alt, and ast. It provides rapid detection of specific genetic targets and can be used to investigate virulence-associated genes.
- Real-Time PCR (qPCR): qPCR enables rapid detection of target bacterial DNA and can be used for quantitative assessment of bacterial load when an appropriate assay is available.
- DNA Sequencing: 16S rRNA gene sequencing can support identification of Aeromonas isolates. Additional genetic targets may sometimes be required to distinguish closely related Aeromonas species.
- MALDI-TOF Mass Spectrometry: MALDI-TOF identifies bacteria based on characteristic protein spectral patterns. It provides rapid identification and is widely used in modern clinical microbiology laboratories.
Treatment of Aeromonas hydrophila
- Treatment: Management depends on the site and severity of infection, the patient's clinical condition, and antimicrobial susceptibility results.
- Mild Gastroenteritis: Mild cases are often self-limiting and may be managed with oral rehydration therapy, adequate fluid and electrolyte replacement, and nutritional support.
- Severe Gastroenteritis: Antimicrobial therapy may be considered in severe or prolonged diarrhea, systemic symptoms, or patients with significant risk factors. Antibiotic selection should preferably be guided by culture and antimicrobial susceptibility testing (AST).
- Fluid Therapy: Intravenous fluids may be required when dehydration is severe or oral fluid replacement is inadequate.
- Commonly Used Antimicrobials: Depending on susceptibility and clinical circumstances, antimicrobial options may include trimethoprim-sulfamethoxazole, fluoroquinolones such as ciprofloxacin or levofloxacin, and selected third-generation cephalosporins such as ceftriaxone.
- Trimethoprim-Sulfamethoxazole: May be used for susceptible infections; the dose and duration should be determined according to the infection, patient factors, and current clinical guidelines.
- Ciprofloxacin: A fluoroquinolone that may be used for susceptible Aeromonas infections, particularly in appropriate adult patients.
- Levofloxacin: Another fluoroquinolone that may be considered when the isolate is susceptible.
- Third-Generation Cephalosporins: Agents such as ceftriaxone may be used for susceptible infections, particularly in more serious infections.
- Skin and Soft Tissue Infections: Treatment includes appropriate wound management together with antimicrobial therapy when clinically indicated.
- Local Wound Care: Wounds should be thoroughly cleaned and irrigated, necrotic tissue should be removed when necessary, and appropriate dressing changes should be performed.
- Severe Skin and Soft Tissue Infections: Abscesses may require surgical drainage, while extensive necrotic tissue may require surgical debridement.
- Antibiotic Therapy for Severe Infections: Antimicrobial selection should be based on the clinical severity and susceptibility results. Severe infections may require intravenous therapy and specialist management.
- Treatment Duration: Duration depends on the site and severity of infection and the patient's response to treatment. Uncomplicated infections may require shorter courses, whereas severe or systemic infections generally require longer treatment.
- Bloodstream Infections: Bacteremia and septicemia require prompt antimicrobial therapy, usually with an agent active against the patient's isolate and appropriate for the severity of disease. Treatment duration is commonly longer than that used for uncomplicated localized infections.
- Immunocompromised Patients: These patients may require closer monitoring and individualized antimicrobial therapy. Treatment may need to be prolonged depending on the infection and clinical response.
- Treatment Monitoring: Patients with severe or systemic infection should be monitored closely for clinical improvement, treatment failure, complications, and antimicrobial resistance.
- Pediatric Patients: Antimicrobial selection should be based on age, infection severity, susceptibility results, and pediatric treatment guidelines. Trimethoprim-sulfamethoxazole or appropriate third-generation cephalosporins may be used when indicated.
- Doxycycline in Children: Doxycycline is generally avoided in younger children unless specifically indicated by a clinician because its use depends on the child's age and clinical circumstances.
Prevention and Control of Aeromonas hydrophila
- Consume properly treated and chlorinated drinking water.
- Boil water before consumption when the safety of the water source is uncertain.
- Protect wells and other water sources from sewage and wastewater contamination.
- Regularly monitor water quality for microbial contamination.
- Avoid swimming or bathing in contaminated ponds, rivers, or other potentially contaminated water sources.
- Thoroughly cook fish, seafood, and other aquatic products before consumption.
- Avoid consuming raw or undercooked seafood.
- Prevent cross-contamination between raw and cooked foods during preparation and storage.
- Maintain proper refrigeration and appropriate food storage conditions.
- Wash hands thoroughly with soap and clean water before eating, after handling fish or seafood, and after contact with potentially contaminated water.
- Cover cuts, abrasions, burns, and other open wounds to reduce the risk of infection.
- Avoid exposing open wounds to potentially contaminated freshwater or other aquatic environments.
- Clean and disinfect wounds promptly after accidental exposure to potentially contaminated water.
- Maintain proper sterilization and disinfection of medical instruments, equipment, and solutions to reduce healthcare-associated transmission.
Conclusion
- Aeromonas hydrophila is a ubiquitous Gram-negative bacterium commonly found in freshwater environments and is recognized as an important opportunistic pathogen of humans and animals.
- Transmission occurs primarily through ingestion of contaminated food or water, exposure of wounds to contaminated aquatic environments, and contact with infected animals.
- Its pathogenicity is mediated by multiple virulence factors, including aerolysin, hemolysin, enterotoxins, flagella, pili, biofilm formation, lipopolysaccharide (LPS), and extracellular enzymes that contribute to colonization, tissue damage, invasion, and immune evasion.
- Clinical manifestations range from gastrointestinal disease, including diarrhea, abdominal pain, nausea, and vomiting, to wound infections, cellulitis, bacteremia, septicemia, and severe necrotizing infections.
- Laboratory diagnosis involves a combination of culture, colony morphology, biochemical testing, commercial identification systems, and molecular methods.
- Treatment depends on the site and severity of infection and should be guided by antimicrobial susceptibility testing when possible.
- Prevention and control rely on safe drinking water, proper food hygiene, thorough cooking of seafood, environmental sanitation, appropriate wound care, and avoidance of exposure of open wounds to potentially contaminated water.
- Overall, A. hydrophila remains an important water- and food-associated pathogen, and effective management requires timely laboratory diagnosis, appropriate clinical treatment, and comprehensive preventive measures.
References
- Elsevier. (n.d.). Aeromonas hydrophila. ScienceDirect Topics. https://www.sciencedirect.com/topics/medicine-and-dentistry/aeromonas-hydrophila
- Public Health Agency of Canada. (2011, January 4). Pathogen safety data sheet: Infectious substances – Aeromonas hydrophila. Government of Canada. https://www.canada.ca/en/public-health/services/laboratory-biosafety-biosecurity/pathogen-safety-data-sheets-risk-assessment/aeromonas-hydrophila.html
- Biofargo. (2026, April 9). Aeromonas hydrophila: Pathogenic mechanisms and PCR detection. https://biofargo.com/blogs/news/aeromonas-hydrophila-detection-pathogenesis-guide
- Microbe Canvas. (n.d.). Aeromonas hydrophila. https://www.microbe-canvas.com/Bacteria/gram-negative-rods/facultative-anaerobic-3/catalase-positive-3/oxidase-positive/indole-positive-3/aeromonas-hydrophila.html
- Abo-Shama, U. H., Abd El Raheem, A. A., Alsaadawy, R. M., & Sayed, H. H. (2025). Phenotypic and genotypic characterization of Aeromonas hydrophila isolated from freshwater fishes at Middle Upper Egypt. Scientific Reports, 15, 5920. https://doi.org/10.1038/s41598-025-89465-4
- Medical Lab Notes. (2022, November 22). Aeromonas hydrophila: Introduction, identification features, keynotes, and Aeromonas footages. https://medicallabnotes.com/aeromonas-hydrophila/
- Aryal, S. (2022, March 21). Biochemical test of Aeromonas hydrophila. Microbe Notes. https://microbenotes.com/biochemical-test-of-aeromonas-hydrophila/
- Semwal, A., Kumar, A., & Kumar, N. (2023). A review on the pathogenicity of Aeromonas hydrophila and their mitigation through medicinal herbs in aquaculture. Heliyon, 9(3), e14088. https://doi.org/10.1016/j.heliyon.2023.e14088
- Tomás, J. M. (2012). The main Aeromonas pathogenic factors. ISRN Microbiology, 2012, 256261. https://doi.org/10.5402/2012/256261
- Rasmussen-Ivey, C. R., Figueras, M. J., McGarey, D., & Liles, M. R. (2016). Virulence factors of Aeromonas hydrophila: In the wake of reclassification. Frontiers in Microbiology, 7, 1337. https://doi.org/10.3389/fmicb.2016.01337
- Pessoa, R. B. G., de Oliveira, W. F., Correia, M. T. D. S., Fontes, A., & Coelho, L. C. B. B. (2022). Aeromonas and human health disorders: Clinical approaches. Frontiers in Microbiology, 13, 868890. https://doi.org/10.3389/fmicb.2022.868890
- Artati, D., Oman, M., Supriyanto, S., Sukarta, D., & Robisalmi, A. (2024). Validation of analytical method for Aeromonas hydrophila identification using the Analytical Profile Index (API) 20E KIT method. Jurnal Medik Veteriner, 7(1), 88–104. https://doi.org/10.20473/jmv.vol7.iss1.2024.88-104
- Calvo Sánchez, N., Sancha Domínguez, L., Cotos Suárez, A., & Muñoz Bellido, J. L. (2025). Aeromonas infections in humans—Antibiotic resistance and treatment options. Pathogens, 14(11), 1161. https://doi.org/10.3390/pathogens14111161
- Dr.Oracle Medical Advisory Board. (2025, October 5). What is the recommended treatment for Aeromonas infections? Dr.Oracle. https://www.droracle.ai/articles/387660/what-is-the-recommended-treatment-for-aeromonas-infections
